J Leukoc Biol (2005) 77:598625
GIP receptor activation in the brain may contribute to appetite regulation through mechanisms distinct from GLP-1 signaling, potentially explaining tirzepatide's superior weight loss compared to GLP-1 monoagonists
In addition, PGA and Kyn/Trp may have potential as biomarkers for disease monitoring and risk stratification, although their clinical utility will require validation in independent and longitudinal cohorts
It includes detailed quality, manufacturing, and stability data
Always consult with a healthcare provider before starting any new peptide therapy, as these compounds can have powerful effects and may interact with other medications or treatments
References Abou Zeina HA, Zaghawa A, Radwan ME, El-Rahim Ih A (2009) Oxidative stress and immune response in animals vaccinated with irradiated pasteurella multocida vaccine and treated with antioxidants